tricalcium phosphate has been researched along with Bisphosphonate Osteonecrosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Patntirapong, S; Phupunporn, P; Thanetchaloempong, W; Vanichtantiphong, D | 1 |
| Ávila Souza, F; de Souza Rodrigues, LG; Hadad, H; Kawamata de Jesus, L; Maiorana, C; Marcantonio Junior, E; Milanezi de Almeida, J; Okamoto, R; Paolo Poli, P; Piquera Santos, AF; Pozzi Semeghini Guastaldi, F; Rinaldi Matheus, H | 1 |
| Aung, KT; Dang, AT; Hara, ES; Ishibashi, K; Kuboki, T; Mikai, A; Nawachi, K; Ono, M; Ono-Kimura, A; Oohashi, T; Tanaka, Y; Tosa, I | 1 |
| Funayama, N; Imada, M; Kirita, T; Nakagawa, Y; Ueyama, Y; Yagyuu, T | 1 |
| Hara, ES; Kimura-Ono, A; Kuboki, T; Mikai, A; Nawachi, K; Nguyen, HTT; Nosho, S; Ono, M; Oohashi, T; Takarada, T; Tosa, I | 1 |
| Blanquer, M; Gonzálvez-García, M; Moraleda, JM; Oñate-Sánchez, R; Rodríguez-González, MA; Rodríguez-Lozano, FJ; Segarra-Fenoll, D; Villanueva, V | 1 |
6 other study(ies) available for tricalcium phosphate and Bisphosphonate Osteonecrosis
| Article | Year |
|---|---|
Inhibition of macrophage viability by bound and free bisphosphonates.
Topics: Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Calcium Phosphates; Cell Survival; Diphosphonates; Macrophages; Mice; RAW 264.7 Cells | 2019 |
Beta tricalcium phosphate, either alone or in combination with antimicrobial photodynamic therapy or doxycycline, prevents medication-related osteonecrosis of the jaw.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Calcium Phosphates; Diphosphonates; Doxycycline; Photochemotherapy; Rats; Rats, Wistar; Saline Solution; Tooth Extraction; Zoledronic Acid | 2022 |
Suppression of Bone Necrosis around Tooth Extraction Socket in a MRONJ-like Mouse Model by E-rhBMP-2 Containing Artificial Bone Graft Administration.
Topics: Alveolar Bone Loss; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Transplantation; Calcium Phosphates; Cyclophosphamide; Diphosphonates; Disease Models, Animal; Female; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Recombinant Proteins; Tooth Extraction; Transforming Growth Factor beta; Wound Healing; Zoledronic Acid | 2021 |
Impact of beta-tricalcium phosphate on preventing tooth extraction-triggered bisphosphonate-related osteonecrosis of the jaw in rats.
Topics: Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Calcium Phosphates; Dental Care; Humans; Rats; Tooth Extraction; Zoledronic Acid | 2023 |
BMP-2/β-TCP Local Delivery for Bone Regeneration in MRONJ-Like Mouse Model.
Topics: Animals; Biocompatible Materials; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Regeneration; Calcium Phosphates; Disease Models, Animal; Female; Humans; Mice; Mice, Inbred C57BL; Recombinant Proteins | 2020 |
Cell therapy in bisphosphonate-related osteonecrosis of the jaw.
Topics: Aged; Autografts; Biocompatible Materials; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Marrow Transplantation; Bone Matrix; Bone Regeneration; Bone Substitutes; Calcium Phosphates; Debridement; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Injections, Intravenous; Mandibular Diseases; Multiple Myeloma; Platelet-Rich Plasma; Stem Cell Transplantation; Zoledronic Acid | 2013 |